2031 年までの北米放射線腫瘍学市場予測 - 地域分析 - タイプ別 (外部放射線療法および内部放射線療法) および用途別 (乳がん、前立腺がん、肺がん、頭頸部がん、子宮頸がん、その他)
がんの罹患率の増加が北米の放射線腫瘍学市場を活性化
がんは、世界中の社会に大きな影響を与えている一般的な健康状態の1つです。世界保健機関（WHO）によると、がんは世界中で主な死亡原因であり、2023年には970万人が死亡し、2000万人が新たにがんを発症し、2050年までに約3500万人が新たにがんを発症すると予想されています。WHO 2024レポートによると、肺がんは世界で最も一般的ながんで、死亡原因の第1位であり、次いで大腸がん、肝臓がん、乳がん、胃がんが続き、それぞれ総死亡数の18.7％、9.3％、7.8％、6.9％、6.8％を占めています。
がんの有病率と発生率の増加により、効果的な治療法の需要が生まれています。放射線療法は、がん患者に対する効果的な治療選択肢の1つであり、X線、ガンマ線などの高線量の放射線を利用してがん細胞を死滅させます。放射線療法はがんの初期段階で使用され、さまざまな種類の外部放射線療法がさまざまながんの治療に使用されます。たとえば、小線源療法は、乳がん、子宮頸がん、眼がん、前立腺がん、頭頸部がんの治療に使用されます。同様に、全身放射線療法は放射性ヨウ素としても知られ、甲状腺がんの治療に使用されます。放射線療法は治療のどの時点でも使用でき、手術、化学療法、免疫療法などの他の治療と組み合わせることができます。したがって、がんの罹患率の増加と腫瘍学における放射線療法の進化は、放射線腫瘍学市場の成長を促進すると予想されます。
北米放射線腫瘍学市場の概要
放射線療法は米国のすべてのがん患者に広く利用可能であり、放射線腫瘍医の必要性は継続的に増加しています。これらの専門家の数も、医療インフラの発達により継続的に増加しています。それにもかかわらず、米国臨床腫瘍学会は、世界中のがん患者の約3分の2が治療の一環として放射線療法を受けていると推定しています。 2023年には、米国で年間100万人以上のがん患者が放射線療法を受けると予測されています。政府と医療当局は、放射線療法の採用を促進するためにいくつかの取り組みを行っています。2020年6月、米国放射線腫瘍学会（ASTRO）は、非転移性子宮頸がんの放射線療法に関する新しい臨床ガイドラインを導入しました。新しいガイドラインは、放射線療法を実施するための手順とプロセスを正確に実装することに焦点を当てています。
北米放射線腫瘍学市場の収益と2031年までの予測（百万米ドル）
北米放射線腫瘍学市場のセグメンテーション
北米放射線腫瘍学市場は、タイプ、アプリケーション、および国に分類されています。
タイプに基づいて、北米放射線腫瘍学市場は、外部ビーム放射線療法と内部ビーム放射線療法に分かれています。外部放射線治療セグメントは、2023年に大きな市場シェアを占めました。
用途別に見ると、北米の放射線腫瘍学市場は、乳がん、前立腺がん、肺がん、頭頸部がん、子宮頸がんなどに分類されます。乳がんセグメントは2023年に最大の市場シェアを占めました。
国別に見ると、北米の放射線腫瘍学市場は、米国、カナダ、メキシコに分かれています。2023年には、米国が北米の放射線腫瘍学市場シェアを独占しました。
Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Perspective Therapeutics Inc、NTP RADIOISOTOPES、Mallinckrodt Plc、Provision Healthcare、Curiumは、北米の放射線腫瘍学市場で事業を展開している大手企業の一部です。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. North America Radiation Oncology Market Landscape
4.1 Overview
4.2 PEST Analysis
5. North America Radiation Oncology Market - Key Market Dynamics
5.1 Market Drivers:
5.1.1 Increasing Prevalence of Cancer
5.1.2 Initiatives to Support Developments in Radiation Oncology
5.2 Market Restraints
5.2.1 High Cost of Radiotherapy Equipment
5.3 Market Opportunities
5.3.1 Strategic Initiatives in Radiation Oncology
5.4 Future Trends
5.4.1 Technological Advancement in Radiation Oncology
5.5 Impact of Drivers and Restraints:
6. Radiation Oncology Market - North America Market Analysis
6.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031
7. North America Radiation Oncology Market Analysis - by Types
7.1 External Beam Radiation Therapy
7.1.1 Overview
7.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
7.2.1 Overview
7.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8. North America Radiation Oncology Market Analysis - by Application
8.1 Breast Cancer
8.1.1 Overview
8.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Prostate Cancer
8.2.1 Overview
8.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Lung Cancer
8.3.1 Overview
8.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Head and Neck Cancer
8.4.1 Overview
8.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Cervical Cancer
8.5.1 Overview
8.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
9. North America Radiation Oncology Market - Country Analysis
9.1 North America Radiation Oncology Market Overview
9.1.1 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
9.1.1.1 United States: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
9.1.1.1.1 United States: Radiation Oncology Market Breakdown, by Types
9.1.1.1.2 United States: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.1.1.3 United States: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.1.1.4 United States: Radiation Oncology Market Breakdown, by Application
9.1.1.2 Canada: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
9.1.1.2.1 Canada: Radiation Oncology Market Breakdown, by Types
9.1.1.2.2 Canada: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.1.2.3 Canada: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.1.2.4 Canada: Radiation Oncology Market Breakdown, by Application
9.1.1.3 Mexico: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
9.1.1.3.1 Mexico: Radiation Oncology Market Breakdown, by Types
9.1.1.3.2 Mexico: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.1.3.3 Mexico: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.1.3.4 Mexico: Radiation Oncology Market Breakdown, by Application
10. Radiation Oncology Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies in Radiation Oncology Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Varian Medical Systems Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Elekta AB
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Accuray Incorporated
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 IBA Worldwide (Ion Beam Applications SA)
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Becton Dickinson and Co
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Perspective Therapeutics Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 NTP RADIOISOTOPES
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Mallinckrodt Plc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Provision Healthcare
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Curium
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. North America Radiation Oncology Market Segmentation
Table 2. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 3. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 4. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 5. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 6. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 7. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 8. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 9. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 10. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
Table 11. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
Table 12. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
Table 13. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
Table 14. Recent Organic Growth Strategies in Radiation Oncology Market
Table 15. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 16. Glossary of Terms, Radiation Oncology Market
List of Figures
Figure 1. North America Radiation Oncology Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Radiation Oncology Market - Key Market Dynamics
Figure 4. Statistics at Glance, Global, 2022
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Radiation Oncology Market Revenue (US$ Million), 2021-2031
Figure 7. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
Figure 8. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 10. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
Figure 11. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 14. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. North America Radiation Oncology Market, by Key Countries - Revenue (2023) (US$ Million)
Figure 18. North America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 19. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 20. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 21. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
Figure 22. Growth Strategies in Radiation Oncology Market
- Varian Medical Systems Inc.
- Elekta AB.
- Accuray Incorporated.
- IBA Worldwide (Ion Beam Applications SA).
- Becton Dickinson and Co.
- Perspective Therapeutics Inc.
- NTP RADIOISOTOPES.
- Mallinckrodt Plc.
- Provision Healthcare.
- Curium.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America radiation oncology market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America radiation oncology market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America radiation oncology market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.